Effects of Chengqi Decoction on Complications and Prognosis of Patients with Pneumonia-Derived Sepsis: Retrospective Cohort Study

Table 4

Subgroup analyses of the risk of death in the Chengqi decoction group and control group at 28 days.

Subgroup	Chengqi decoction (n = 141)	Control (n = 141)	HR with Chengqi decoction (95% CI)	P
Age
<65 years, n/total (%)	18/63	36/63	0.30 (0.08–1.08)	0.06
≥65 years, n/total (%)	15/78	27/78	0.45 (0.13–1.70)	0.21
APACHE II score
<25, n/total (%)	27/78	42/84	0.53 (0.18–1.58)	0.25
≥25, n/total (%)	6/63	21/57	0.18 (0.03–1.02)	0.04
Lactate (mmol/L)
<2, n/total (%)	15/81	24/60	0.34 (0.09–1.28)	0.10
≥2, n/total (%)	18/60	39/81	0.46 (0.14–1.56)	0.21
NT-proBNP (pg/mL)
<1800, n/total (%)	3/54	6/12	0.06 (0.01–0.98)	0.02
≥1800, n/total (%)	30/87	57/129	0.67 (0.25–1.76)	0.41

HR, hazard ratio; APACHE, Acute Physiology and Chronic Health Evaluation.